The Protect Patient Access to Pharmacies Act (S. 2052) was recently introduced to provide long-sought reform of pharmacy direct and indirect remuneration (DIR) fees that are jeopardizing seniors, pharmacists, pharmacies, and communities. NACDS RxIMPACT needs your help urging U.S. Senators to support pharmacy DIR fee reform as one very important part of comprehensive pharmacy benefit manager (PBM) reform!
As seen in the video at https://vimeo.com/793466461, PBM “pharmaceutical benefit manipulators” profit at the expense of patients, pharmacies, employers, taxpayers, and communities. PBM retroactive fees and claw backs – known as DIR fees – occur months after transactions close and devastate rural and urban pharmacies’ economic viability. Fees have risen 107,400% between 2010 and 2020, with pharmacy payments to PBMs up 50.4% from 2018 to 2020. Contrary to PBMs’ claims, The Centers for Medicare & Medicaid Services’ Calendar Year 2024 Part D Final Rule did not end pharmacy DIR claw backs.
U.S. Senator Jon Tester (D-MT) authored the Protect Patient Access to Pharmacies Act to bring about comprehensive DIR fee reform – which remains necessary. The bill embraces key aspects of NACDS’ Principles of PBM reform. The bill would reform pharmacy DIR fees that are jeopardizing seniors, pharmacists, pharmacies, and communities, and it would enforce “any willing pharmacy” requirements.
U.S. Senators Sherrod Brown (D-OH), Shelley Moore Capito (R-WV), and James Lankford (R-OK) have already enlisted to support this critical bipartisan legislation. Join this NACDS RxIMPACT effort TODAY to urge your U.S. Senators to put patients and the pharmacies that serve them ahead of PBM profits by co-sponsoring the Protect Patient Access to Pharmacies Act! To act, simply enter your contact information, click "Send Message" and the system will send personalized messages to your U.S. Senators.
If you have any questions or would like any assistance, please contact Heidi Ecker via telephone at 703-837-4121 or email.
As seen in the video at https://vimeo.com/793466461, PBM “pharmaceutical benefit manipulators” profit at the expense of patients, pharmacies, employers, taxpayers, and communities. PBM retroactive fees and claw backs – known as DIR fees – occur months after transactions close and devastate rural and urban pharmacies’ economic viability. Fees have risen 107,400% between 2010 and 2020, with pharmacy payments to PBMs up 50.4% from 2018 to 2020. Contrary to PBMs’ claims, The Centers for Medicare & Medicaid Services’ Calendar Year 2024 Part D Final Rule did not end pharmacy DIR claw backs.
U.S. Senator Jon Tester (D-MT) authored the Protect Patient Access to Pharmacies Act to bring about comprehensive DIR fee reform – which remains necessary. The bill embraces key aspects of NACDS’ Principles of PBM reform. The bill would reform pharmacy DIR fees that are jeopardizing seniors, pharmacists, pharmacies, and communities, and it would enforce “any willing pharmacy” requirements.
U.S. Senators Sherrod Brown (D-OH), Shelley Moore Capito (R-WV), and James Lankford (R-OK) have already enlisted to support this critical bipartisan legislation. Join this NACDS RxIMPACT effort TODAY to urge your U.S. Senators to put patients and the pharmacies that serve them ahead of PBM profits by co-sponsoring the Protect Patient Access to Pharmacies Act! To act, simply enter your contact information, click "Send Message" and the system will send personalized messages to your U.S. Senators.
If you have any questions or would like any assistance, please contact Heidi Ecker via telephone at 703-837-4121 or email.
By providing your mobile number, you agree to receive periodic call to action text messages from National Association of Chain Drug Stores. Message and data rates may apply. Reply HELP for help. Reply STOP to unsubscribe. Message frequency varies.
Privacy Policy
*